4-(5-Chloro-3-(3,4,5-trimethoxybenzoyl)-1H-indol-1-yl) benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β-Catenin Signaling Pathway, and P-Glycoprotein
Fields of Study & Subjects
Enzyme function and inhibition
Heterocyclic Compound Synthesis and Bioactivity
Drug Transport and Resistance Mechanisms
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 4 March 2026
- Language
- EN